Reference health
The Inversion of IL-6 Levels in Relation to C-Reactive Protein as the Marker for Cytokine Storm Syndrome in COVID-19
37/37 checkable references clean · checked 2026-07-23
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
25 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
The 37 checked references that resolve
resolves10.1001/jama.2020.6775
Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area
resolves10.1038/s41586-020-2012-7
A pneumonia outbreak associated with a new coronavirus of probable bat origin
resolves10.1038/s41591-020-1051-9
An inflammatory cytokine signature predicts COVID-19 severity and survival
resolves10.3389/fimmu.2020.01626
Overview: Systemic Inflammatory Response Derived From Lung Injury Caused by SARS-CoV-2 Infection Explains Severe Outcomes in COVID-19
resolves10.1186/s12916-020-01682-y
Could hemophagocytic lymphohistiocytosis be the core issue of severe COVID-19 cases?
resolves10.1016/j.chom.2020.05.007
Favorable Anakinra Responses in Severe Covid-19 Patients with Secondary Hemophagocytic Lymphohistiocytosis
resolves10.1038/s41379-020-0613-1
Histiocytic hyperplasia with hemophagocytosis and acute alveolar damage in COVID-19 infection
resolves10.1186/s13256-020-02503-9
Hemophagocytic lymphohistiocytosis in a patient with COVID-19 treated with tocilizumab: a case report
resolves10.1007/s10067-020-05073-9
Rheumatologists’ perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets
resolves10.1002/(SICI)1096-911X(199705)28:5<342::AID-MPO3>3.0.CO;2-H
HLH-94: A treatment protocol for hemophagocytic lymphohistiocytosis
resolves10.1016/j.jpeds.2012.11.081
Differentiating Macrophage Activation Syndrome in Systemic Juvenile Idiopathic Arthritis from Other Forms of Hemophagocytic Lymphohistiocytosis
resolves10.1097/RHU.0b013e31829ce01f
Causes and Significance of Markedly Elevated Serum Ferritin Levels in an Academic Medical Center
resolves10.1016/j.jinf.2004.09.008
The use of corticosteroid as treatment in SARS was associated with adverse outcomes: a retrospective cohort study
resolves10.1164/rccm.200306-766OC
High–Dose Pulse Versus Nonpulse Corticosteroid Regimens in Severe Acute Respiratory Syndrome
resolves10.1016/j.jcv.2020.104362
Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past
resolves10.1086/591708
Predominant Role of Bacterial Pneumonia as a Cause of Death in Pandemic Influenza: Implications for Pandemic Influenza Preparedness
resolves10.1016/j.cmi.2020.07.016
Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis
resolves10.1136/bmj.38483.478183.EB
Diagnostic value of C reactive protein in infections of the lower respiratory tract: systematic review
resolves10.1038/s41577-020-0331-4
Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages
resolves10.1016/j.cmi.2020.09.041
Recommendations for antibacterial therapy in adults with COVID-19 – an evidence based guideline
resolves10.1136/rmdopen-2020-001295
Storm, typhoon, cyclone or hurricane in patients with COVID-19? Beware of the same storm that has a different origin
resolves10.1007/s10067-020-05190-5
Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment
resolves10.1016/S0140-6736(20)30317-2
Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury
resolves10.1182/blood-2014-10-602607
Marked hyperferritinemia does not predict for HLH in the adult population
resolves10.1016/j.autrev.2020.102573
COVID-19 gone bad: A new character in the spectrum of the hyperferritinemic syndrome?
resolves10.1007/s12026-020-09145-5
COVID-19 as part of the hyperferritinemic syndromes: the role of iron depletion therapy
The 25 references without a DOI — listed, not checked
no DOI — not checkedClinical features of patients infected with 2019 novel coronavirus in Wuhan
no DOI — not checkedPredictive monitoring and therapeutic immune biomarkers in the management of clinical complications of COVID-19
no DOI — not checkedImmune cartography of macrophage activation syndrome in the COVID-19 era
no DOI — not checkedThe pathogenesis and treatment of the 'Cytokine Storm' in COVID-19
no DOI — not checkedThrombocytopenia and Its Association with Mortality in Patients with COVID-19.pdf
no DOI — not checkedMechanism of thrombocytopenia in COVID-19 patients
no DOI — not checkedref28
no DOI — not checkedHematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a metaanalysis
no DOI — not checkedAnticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy
no DOI — not checkedThe procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome
no DOI — not checkedRisk Factors Associated with Acute Respiratory Distress Syndrome and Death in Patients with Coronavirus Disease
no DOI — not checkedref39
no DOI — not checkedImplementation of C-reactive protein point of care testing to improve antibiotic targeting in respiratory illness in Vietnamese primary care (ICAT): A study protocol for a cluster randomised controlled trial
no DOI — not checkedBiomarkers as point-of-care tests to guide prescription of antibiotics in patients with acute respiratory infections in primary care
no DOI — not checkedref42
no DOI — not checkedMild or Moderate Covid-19
no DOI — not checkedReport from the American Society for Microbiology COVID-19 COVID-19
no DOI — not checkedref49
no DOI — not checkedThe COVID-19 lab score
no DOI — not checkedref55
no DOI — not checkedref56
no DOI — not checkedref59
no DOI — not checkedThe Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease
no DOI — not checked61 Histiocyte Society. Recommendations and Considerations from the Histiocyte Society During the Evaluation of Hospitalized COVID-19 Patients for Hyperinflammation
no DOI — not checkedAssociation between platelet parameters and mortality in coronavirus disease
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.2139/ssrn.4001787"><img src="https://citestamp.com/citestamped/10.2139/ssrn.4001787/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.2139/ssrn.4001787)